Volastra Therapeutics

Volastra Therapeutics is a biotechnology company focused on developing innovative therapies to combat cancer by targeting chromosomal instability, a hallmark of cancer cells. They make money through research and development partnerships, grants, and potential future revenues from successful drug commercialization. Founded in 2019, Volastra leverages cutting-edge scientific research and collaborations with leading academic institutions to advance its pipeline of novel cancer treatments.

Recent Posts by Volastra Therapeutics

1-8 of 8